A Pan-Cancer Analysis of the Oncogenic Role of Integrin Beta4 (ITGB4) in Human Tumors

References

• Second call for pan-cancer analysis. Nat Genet. 2014;46(12):1251. doi:10.1038/ng.3155
   PubMed Web of Science ®Google Scholar
• Sheppard D. Functions of pulmonary epithelial integrins: from development to disease. Physiol Rev. 2003;83(3):673–686. doi:10.1152/physrev.00033.2002
   PubMed Web of Science ®Google Scholar
• Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol. 2004;5(10):816–826. doi:10.1038/nrm1490
   PubMed Web of Science ®Google Scholar
• Huang W, Yan Y, Liu Y, et al. Exosomes with low miR-34c-3p expression promote invasion and migration of non-small cell lung cancer by upregulating integrin α2β1. Signal Transd Targeted Ther. 2020;5(1):39. doi:10.1038/s41392-020-0133-y
   PubMed Web of Science ®Google Scholar
• Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110(6):673–687. doi:10.1016/s0092-8674(02)00971-6
   PubMed Web of Science ®Google Scholar
• Thuveson M, Gaengel K, Collu GM, Chin ML, Singh J, Mlodzik M. Integrins are required for synchronous ommatidial rotation in the Drosophila eye linking planar cell polarity signalling to the extracellular matrix. Open Biol. 2019;9(8):190148. doi:10.1098/rsob.190148
   PubMed Web of Science ®Google Scholar
• Giancotti FG. Targeting integrin beta4 for cancer and anti-angiogenic therapy. Trends Pharmacol Sci. 2007;28(10):506–511. doi:10.1016/j.tips.2007.08.004
   PubMed Web of Science ®Google Scholar
• Giancotti FG, Tarone G. Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu Rev Cell Dev Biol. 2003;19:173–206. doi:10.1146/annurev.cellbio.19.031103.133334
   PubMed Web of Science ®Google Scholar
• Mercurio AM, Bachelder RE, Rabinovitz I, O’Connor KL, Tani T, Shaw LM. The metastatic odyssey: the integrin connection. Surg Oncol Clin N Am. 2001;10(2):313–328, viii–ix.
   PubMedGoogle Scholar
• Mercurio AM, Rabinovitz I. Towards a mechanistic understanding of tumor invasion–lessons from the alpha 6 beta 4 integrin. Semin Cancer Biol. 2001;11(2):129–141. doi:10.1006/scbi.2000.0364
   PubMed Web of Science ®Google Scholar
• Nikolopoulos SN, Blaikie P, Yoshioka T, Guo W, Giancotti FG. Integrin beta4 signaling promotes tumor angiogenesis. Cancer Cell. 2004;6(5):471–483. doi:10.1016/j.ccr.2004.09.029
   PubMed Web of Science ®Google Scholar
• Masugi Y, Yamazaki K, Emoto K, et al. Upregulation of integrin β4 promotes epithelial-mesenchymal transition and is a novel prognostic marker in pancreatic ductal adenocarcinoma. Lab Invest. 2015;95(3):308–319. doi:10.1038/labinvest.2014.166
   PubMed Web of Science ®Google Scholar
• Nieto MA, Huang RY, Jackson RA, Thiery JP. EMT: 2016. Cell. 2016;166(1):21–45. doi:10.1016/j.cell.2016.06.028
   PubMed Web of Science ®Google Scholar
• Diaz LK, Cristofanilli M, Zhou X, et al. Beta4 integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancer. Mod Pathol. 2005;18(9):1165–1175. doi:10.1038/modpathol.3800411
   PubMed Web of Science ®Google Scholar
• Kitajiri S, Hosaka N, Hiraumi H, Hirose T, Ikehara S. Increased expression of integrin beta-4 in papillary thyroid carcinoma with gross lymph node metastasis. Pathol Int. 2002;52(7):438–441. doi:10.1046/j.1440-1827.2002.01379.x
   PubMed Web of Science ®Google Scholar
• Kurokawa A, Nagata M, Kitamura N, et al. Diagnostic value of integrin alpha3, beta4, and beta5 gene expression levels for the clinical outcome of tongue squamous cell carcinoma. Cancer. 2008;112(6):1272–1281. doi:10.1002/cncr.23295
   PubMed Web of Science ®Google Scholar
• Bierie B, Pierce SE, Kroeger C, et al. Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells. Proc Natl Acad Sci USA. 2017;114(12):E2337–E2346. doi:10.1073/pnas.1618298114
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia (New York, NY). 2017;19(8):649–658. doi:10.1016/j.neo.2017.05.002
   PubMed Web of Science ®Google Scholar
• Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–404. doi:10.1158/2159-8290.cd-12-0095
   PubMed Web of Science ®Google Scholar
• Bonneville R, Krook MA, Kautto EA, et al. Landscape of microsatellite instability across 39 cancer types. JCO Precision Oncol. 2017;2017. doi:10.1200/po.17.00073
   PubMed Web of Science ®Google Scholar
• Sturm G, Finotello F, Petitprez F, et al. Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology. Bioinformatics (Oxford, England). 2019;35(14):i436–i445. doi:10.1093/bioinformatics/btz363
   PubMed Web of Science ®Google Scholar
• Bardou P, Mariette J, Escudié F, Djemiel C, Klopp C. jvenn: an interactive Venn diagram viewer. BMC Bioinform. 2014;15(1):293. doi:10.1186/1471-2105-15-293
   PubMed Web of Science ®Google Scholar
• Beausoleil SA, Villén J, Gerber SA, Rush J, Gygi SP. A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat Biotechnol. 2006;24(10):1285–1292. doi:10.1038/nbt1240
   PubMed Web of Science ®Google Scholar
• Fridman WH, Galon J, Dieu-Nosjean MC, et al. Immune infiltration in human cancer: prognostic significance and disease control. Curr Top Microbiol Immunol. 2011;344:1–24. doi:10.1007/82_2010_46
   PubMed Web of Science ®Google Scholar
• Wu T, Dai Y. Tumor microenvironment and therapeutic response. Cancer Lett. 2017;387:61–68. doi:10.1016/j.canlet.2016.01.043
   PubMed Web of Science ®Google Scholar
• Chen X, Song E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov. 2019;18(2):99–115. doi:10.1038/s41573-018-0004-1
   PubMed Web of Science ®Google Scholar
• Friedrichs K, Ruiz P, Franke F, Gille I, Terpe HJ, Imhof BA. High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res. 1995;55(4):901–906.
   PubMed Web of Science ®Google Scholar
• Gao S, Jia B, Feng G, et al. First-in-human pilot study of an integrin α6-targeted radiotracer for SPECT imaging of breast cancer. Signal Transd Targeted Ther. 2020;5(1)):147. doi:10.1038/s41392-020-00266-9
   PubMed Web of Science ®Google Scholar
• Takada Y, Ye X, Simon S. The integrins. Genome Biol. 2007;8(5):215. doi:10.1186/gb-2007-8-5-215
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang H, Han F, et al. The depletion of MARVELD1 leads to murine placenta accreta via integrin β4-dependent trophoblast cell invasion. J Cell Physiol. 2018;233(3):2257–2269. doi:10.1002/jcp.26098
   PubMed Web of Science ®Google Scholar
• Fabre S, Chantepie L, Plisson-Petit F, et al. A novel homozygous nonsense mutation in ITGB4 gene causes epidermolysis bullosa in Mouton Vendéen sheep. Anim Genet. 2021;52(1):138–139. doi:10.1111/age.13026
   PubMed Web of Science ®Google Scholar
• Mueller CK, Thorwarth M, Chen J, Schultze-Mosgau S. A laboratory study comparing the effect of ridge exposure using tissue punch versus mucoperiosteal flap on the formation of the implant-epithelial junction. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(5 Suppl):S41–45. doi:10.1016/j.tripleo.2011.08.019
   PubMed Web of Science ®Google Scholar
• Van der Zee CE, Kreft M, Beckers G, Kuipers A, Sonnenberg A. Conditional deletion of the Itgb4 integrin gene in Schwann cells leads to delayed peripheral nerve regeneration. J Neurosci. 2008;28(44):11292–11303. doi:10.1523/jneurosci.3068-08.2008
   PubMed Web of Science ®Google Scholar
• Li M, Jiang X, Wang G, et al. ITGB4 is a novel prognostic factor in colon cancer. J Cancer. 2019;10(21):5223–5233. doi:10.7150/jca.29269
   PubMed Web of Science ®Google Scholar
• Wang S, Li J, Xie J, et al. Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin β4/SNAI1/SIRT3 signaling pathway. Oncogene. 2018;37(30):4164–4180. doi:10.1038/s41388-018-0252-x
   PubMed Web of Science ®Google Scholar
• Wilkinson EJ, Woodworth AM, Parker M, et al. Epigenetic regulation of the ITGB4 gene in prostate cancer. Exp Cell Res. 2020;392(2):112055. doi:10.1016/j.yexcr.2020.112055
   PubMed Web of Science ®Google Scholar
• Li GS, Hou W, Chen G, et al. Clinical significance of integrin subunit Beta 4 in head and neck squamous cell carcinoma. Cancer Biother Radiopharm. 2020. doi:10.1089/cbr.2020.3943
   Web of Science ®Google Scholar
• Wu P, Wang Y, Wu Y, Jia Z, Song Y, Liang N. Expression and prognostic analyses of ITGA11, ITGB4 and ITGB8 in human non-small cell lung cancer. PeerJ. 2019;7:e8299. doi:10.7717/peerj.8299
   PubMed Web of Science ®Google Scholar
• Li XL, Liu L, Li DD, et al. Integrin β4 promotes cell invasion and epithelial-mesenchymal transition through the modulation of Slug expression in hepatocellular carcinoma. Sci Rep. 2017;7:40464. doi:10.1038/srep40464
   PubMed Web of Science ®Google Scholar
• Tagliabue E, Ghirelli C, Squicciarini P, Aiello P, Colnaghi MI, Ménard S. Prognostic value of alpha 6 beta 4 integrin expression in breast carcinomas is affected by laminin production from tumor cells. Clin Cancer Res. 1998;4(2):407–410.
   PubMed Web of Science ®Google Scholar
• Brendle A, Lei H, Brandt A, et al. Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. Carcinogenesis. 2008;29(7):1394–1399. doi:10.1093/carcin/bgn126
   PubMed Web of Science ®Google Scholar
• Menyhárt O, Nagy Á, Győrffy B. Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma. R Soc Open Sci. 2018;5(12):181006. doi:10.1098/rsos.181006
   PubMed Web of Science ®Google Scholar
• Mohanty A, Nam A, Pozhitkov A, et al. A non-genetic mechanism involving the integrin β4/paxillin axis contributes to chemoresistance in lung cancer. iScience. 2020;23(9):101496. doi:10.1016/j.isci.2020.101496
   PubMed Web of Science ®Google Scholar
• Huafeng J, Deqing Z, Yong D, Yulian Z, Ailing H. A cross-talk between integrin β4 and epidermal growth factor receptor induces gefitinib chemoresistance to gastric cancer. Cancer Cell Int. 2018;18:50. doi:10.1186/s12935-018-0548-5
   PubMed Web of Science ®Google Scholar
• Gan L, Meng J, Xu M, et al. Extracellular matrix protein 1 promotes cell metastasis and glucose metabolism by inducing integrin β4/FAK/SOX2/HIF-1α signaling pathway in gastric cancer. Oncogene. 2018;37(6):744–755. doi:10.1038/onc.2017.363
   PubMed Web of Science ®Google Scholar
• Hong D, Zhang X, Li R, et al. Deletion of TMEM268 inhibits growth of gastric cancer cells by downregulating the ITGB4 signaling pathway. Cell Death Differ. 2019;26(8):1453–1466. doi:10.1038/s41418-018-0223-3
   PubMed Web of Science ®Google Scholar
• Chen Q, Xu R, Zeng C, et al. Down-regulation of Gli transcription factor leads to the inhibition of migration and invasion of ovarian cancer cells via integrin β4-mediated FAK signaling. PLoS One. 2014;9(2):e88386. doi:10.1371/journal.pone.0088386
   PubMed Web of Science ®Google Scholar
• Choi YP, Kim BG, Gao MQ, Kang S, Cho NH, Targeting ILK and β4 integrin abrogates the invasive potential of ovarian cancer. Biochem Biophys Res Commun. 2012;427(3):642–648. doi:10.1016/j.bbrc.2012.09.114
   PubMed Web of Science ®Google Scholar
• Lee JG, Ahn JH, Jin kim T, Ho lee J, Choi JH. Mutant p53 promotes ovarian cancer cell adhesion to mesothelial cells via integrin β4 and Akt signals. Sci Rep. 2015;5:12642. doi:10.1038/srep12642
   PubMed Web of Science ®Google Scholar
• Jeffers MD, Paxton J, Bolger B, Richmond JA, Kennedy JH, McNicol AM. E-cadherin and integrin cell adhesion molecule expression in invasive and in situ carcinoma of the cervix. Gynecol Oncol. 1997;64(3):481–486. doi:10.1006/gyno.1996.4578
   PubMed Web of Science ®Google Scholar
• Abramov IS, Emelyanova MA, Ryabaya OO, Krasnov GS, Zasedatelev AS, Nasedkina TV. Somatic mutations associated with metastasis in acral melanoma. Mol Biol (Mosk). 2019;53(4):648–653. doi:10.1134/s0026898419040025
   PubMed Web of Science ®Google Scholar
• Litjens SH, de Pereda JM, Sonnenberg A. Current insights into the formation and breakdown of hemidesmosomes. Trends Cell Biol. 2006;16(7):376–383. doi:10.1016/j.tcb.2006.05.004
   PubMed Web of Science ®Google Scholar
• Hamidi H, Ivaska J. Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer. 2018;18(9):533–548. doi:10.1038/s41568-018-0038-z
   PubMed Web of Science ®Google Scholar
• Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 2010;10(1):9–22. doi:10.1038/nrc2748
   PubMed Web of Science ®Google Scholar
• Sung JS, Kang CW, Kang S, et al. ITGB4-mediated metabolic reprogramming of cancer-associated fibroblasts. Oncogene. 2020;39(3):664–676. doi:10.1038/s41388-019-1014-0
   PubMed Web of Science ®Google Scholar
• Klutstein M, Nejman D, Greenfield R, Cedar H. DNA methylation in cancer and aging. Cancer Res. 2016;76(12):3446–3450. doi:10.1158/0008-5472.can-15-3278
   PubMed Web of Science ®Google Scholar
• Zhuang H, Zhou Z, Ma Z, et al. Characterization of the prognostic and oncologic values of ITGB superfamily members in pancreatic cancer. J Cell Mol Med. 2020;24(22):13481–13493. doi:10.1111/jcmm.15990
   PubMed Web of Science ®Google Scholar
• Li L, Gao Y, Wu Q, Cheng ASL, Yip KY. New guidelines for DNA methylome studies regarding 5-hydroxymethylcytosine for understanding transcriptional regulation. Genome Res. 2019;29(4):543–553. doi:10.1101/gr.240036.118
   PubMed Web of Science ®Google Scholar
• Anastasiadi D, Esteve-Codina A, Piferrer F. Consistent inverse correlation between DNA methylation of the first intron and gene expression across tissues and species. Epigenetics Chromatin. 2018;11(1):37. doi:10.1186/s13072-018-0205-1
   PubMed Web of Science ®Google Scholar
• Yamashita K, Hosoda K, Nishizawa N, Katoh H, Watanabe M. Epigenetic biomarkers of promoter DNA methylation in the new era of cancer treatment. Cancer Sci. 2018;109(12):3695–3706. doi:10.1111/cas.13812
   PubMed Web of Science ®Google Scholar
• Meng X, Liu P, Wu Y, et al. Integrin beta 4 (ITGB4) and its tyrosine-1510 phosphorylation promote pancreatic tumorigenesis and regulate the MEK1-ERK1/2 signaling pathway. Bosnian J Basic Med Sci. 2020;20(1):106–116. doi:10.17305/bjbms.2019.4255
   PubMed Web of Science ®Google Scholar